Why enroll in My VYVGART Path?

My VYVGART Path is a patient support program that pairs you with a dedicated Nurse Case Manager (NCM), who can help you navigate insurance, offer resources, talk through your challenges, and more.

NCM=Nurse Case Manager

Information provided by the NCM is not intended or implied to be a substitute for professional medical advice, diagnosis, or treatment. Always consult with a qualified and licensed physician or other healthcare provider regarding your medical condition, treatment, and healthcare needs.

My VYVGART Path may help improve access to treatment

What to expect throughout your treatment journey

See how My VYVGART Path is here to guide you throughout each step of the journey listed below.

Map showing 4 steps: My VYVGART Path enrollment, cost and coverage confirmation, treatment begins, and ongoing support Map showing 4 steps: My VYVGART Path enrollment, cost and coverage confirmation, treatment begins, and ongoing support Map showing 4 steps: My VYVGART Path enrollment, cost and coverage confirmation, treatment begins, and ongoing support

There are 2 options to enroll once your doctor has prescribed you VYVGART Hytrulo:

Option 1

Speak with your doctor and ask to be enrolled in My VYVGART Path.

Option 2

Download the enrollment form.

SELF ENROLLMENT FORM

 

Once enrolled in My VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a wide range of helpful resources.

An NCM works with your support team to help you and your doctor’s office navigate the insurance process and understand your plan’s coverage requirements for VYVGART Hytrulo.

The My VYVGART Path team will complete a benefits investigation to help provide you with personalized information about your insurance coverage, potential financial assistance programs, and possible out-of-pocket costs.

  

As you begin treatment, an NCM is here to answer questions you and your loved ones may have. They can help with things like:

  • Explaining how VYVGART Hytrulo works
  • Helping you understand the treatment process
  • Providing guidance to help discuss treatment goals with your doctor
  • Sharing educational information and resources on the injection process
LEARN MORE
6.1-NCM full illlustration-D

NCM assistance continues through your VYVGART Hytrulo treatment process, providing guidance and teaching you about tracking your abilities, which can inform your discussions with your doctor.

MVP logo

Enroll in My VYVGART Path

There are 2 options to enroll once your doctor has prescribed you VYVGART Hytrulo:

Option 1

Speak with your doctor and ask to be enrolled in My VYVGART Path.

Option 2

Download the enrollment form.

SELF ENROLLMENT FORM

Once enrolled in My VYVGART Path, you will receive a call from an NCM to welcome you into the program. A welcome kit will be mailed to you that includes a wide range of helpful resources.

Image of Margaret, a Nurse Case Manager
Image of Margaret, a Nurse Case Manager
It’s a great feeling to educate patients about a treatment option.

Margaret

Nurse Case Manager

Resources to get you started

What’s Next guide

The "What’s Next?” patient guide outlines next steps as you begin your journey with VYVGART Hytrulo.

Download now

My VYVGART Path brochure

See how the My VYVGART Path Patient Support Program can empower you on your treatment journey.

Download now

VYVGART Co-pay Program brochure

If you have commercial or private insurance, you may be eligible for assistance through the VYVGART Co-pay Program.

Download now

Live VYVIDLY Logo
Live VYVIDLY Logo

Have questions? Call 1-833-VYV-CIDP (1-833-898-2437) to speak with an educator about CIDP, how VYVGART Hytrulo works, study data, cost and coverage, and more.

Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP)

Please see the full Prescribing Information for VYVGART HYTRULO and talk to your doctor.

Do not use VYVGART HYTRULO if you have a serious allergy to efgartigimod alfa, hyaluronidase, or any of the other ingredients in VYVGART HYTRULO. VYVGART HYTRULO can cause serious allergic reactions and a decrease in blood pressure leading to fainting.

VYVGART HYTRULO may cause serious side effects, including:

  • Infection. VYVGART HYTRULO may increase the risk of infection. The most common infections for efgartigimod alfa-fcab-treated patients were urinary tract and respiratory tract infections. Signs or symptoms of an infection may include fever, chills, frequent and/or painful urination, cough, pain and blockage of nasal passages/sinus, wheezing, shortness of breath, fatigue, sore throat, excess phlegm, nasal discharge, back pain, and/or chest pain.
  • Allergic Reactions (hypersensitivity reactions). VYVGART HYTRULO can cause allergic reactions such as rashes, swelling under the skin, and shortness of breath. Hives were also observed in patients treated with VYVGART HYTRULO. Serious allergic reactions, such as trouble breathing and decrease in blood pressure leading to fainting have been reported with efgartigimod alfa-fcab.
  • Infusion-Related Reactions. VYVGART HYTRULO can cause infusion-related reactions. The most frequent symptoms and signs reported with efgartigimod alfa-fcab were high blood pressure, chills, shivering, and chest, abdominal, and back pain.

Tell your doctor if you have signs or symptoms of an infection, allergic reaction, or infusion-related reaction. These can happen while you are receiving your VYVGART HYTRULO treatment or afterward. Your doctor may need to pause or stop your treatment. Contact your doctor immediately if you have signs or symptoms of a serious allergic reaction.

Before taking VYVGART HYTRULO, tell your doctor if you:

  • take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines,
  • have received or are scheduled to receive a vaccine (immunization), or
  • have any allergies or medical conditions, including if you are pregnant or planning to become pregnant, or are breastfeeding.

What are the common side effects of VYVGART HYTRULO?

The most common side effects in efgartigimod-alfa-fcab-treated patients were respiratory tract infection, headache, and urinary tract infection. Additional common side effects with VYVGART HYTRULO are injection site reactions, including rash, redness of the skin, itching sensation, bruising, pain, and hives.

These are not all the possible side effects of VYVGART HYTRULO. Call your doctor for medical advice about side effects. You may report side effects to the US Food and Drug Administration at 1-800-FDA-1088.

What is VYVGART® HYTRULO (efgartigimod alfa and hyaluronidase-qvfc)?

VYVGART HYTRULO is a prescription medicine used for the treatment of adult patients with chronic inflammatory demyelinating polyneuropathy (CIDP)

Please see the full Prescribing Information for VYVGART HYTRULO and talk to your doctor.

Questions? Call 1-833-VYV-CIDP
(1-833-898-2437)

This site is intended for patients and caregivers.

Disclaimer | Privacy Policy | Contact Us | Prescribing Information

VYVGART is a registered trademark of argenx.

VYVGART Hytrulo is a trademark of argenx.

LIVE VYVIDLY is a trademark of argenx.

LIVING VYVIDLY is a trademark of argenx.

For U.S. audiences only.

©2024 argenx 

US-VYV_HYT-24-00523 V1 12/2024

argenx logo